Skip to content
Discover modern home decor ideas, interior design tips, and…

Users Discontinuing Anti-Obesity Jabs Regain Weight at a Quadrupled Rate Than People Using Diet and Exercise

Illustration of pharmaceutical injection and weighing machine
Weight management involves long-term strategies.

New research suggests that individuals who come off new weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass far faster than those who stop traditional lifestyle regimens.

Research printed in a major health publication shows that while overweight people often shed a large proportion of their total mass while using the jabs, the weight returns at an average rate of 0.8 kg per month once they quit.

"Individuals buying such drugs should be cognizant of the risk of quick weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.

Such speed of recovery suggests a return to pre-treatment weight in about 18 months.

Comparing Treatments

The research, which looked at 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting.

Scientists note that people who lose weight through lifestyle changes alone generally see a less rapid weight regain—around 0.1 kg a month—post-intervention.

Explaining the Fast Regain

Experts believe the way of the jabs is key to understanding the amplified regain.

These medications copy a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication results in appetite is unsuppressed, making excessive eating a significant risk."

An Ongoing Condition?

The NHS suggest the jabs for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

A number of clinicians contend that, considering the high risk of weight regain, the treatment should be considered life-long.

This view is supported by drug manufacturers, who state that the results "emphasize the long-term character of excess weight," similar to managing diseases like diabetes.

Patient Accounts

Individuals who have stopped the medication explain a intense return of cravings.

"It was like a switch that goes on and I was suddenly starving," said one woman.

This challenge is exacerbated if users have not developed permanent dietary or behavioural modifications during treatment.

Significant Use

Survey data show that a significant number of adults in the UK have used these injections in the past year, with interest continuing to grow.

  • Use is higher among females than men.
  • The 40s and 50s demographic shows the greatest level of interest.
  • Many obtain the medications through private healthcare rather than the NHS.

Finally, clinicians emphasize that while these medications are powerful agents for weight loss, they are not a standalone cure and lasting health benefits likely depends on combined lifestyle changes.

EP
Written by

Elizabeth Palmer

A UK-based interior designer with over 10 years of experience, specializing in contemporary home styling and sustainable decor solutions.

SpinifyRoom

Type to search articles.